Free Trial

Agilent Technologies (A) Financials

Agilent Technologies logo
$105.19 +2.48 (+2.41%)
As of 04/14/2025 03:58 PM Eastern
Annual Income Statements for Agilent Technologies

Annual Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Consolidated Net Income / (Loss)
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Net Income / (Loss) Continuing Operations
438 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Total Pre-Tax Income
480 544 803 946 919 842 1,360 1,504 1,339 1,521
Total Operating Income
522 615 807 904 941 846 1,347 1,618 1,350 1,488
Total Gross Profit
2,041 2,197 2,399 2,680 2,805 2,837 3,407 3,722 3,465 3,535
Total Revenue
4,038 4,202 4,472 4,914 5,163 5,339 6,319 6,848 6,833 6,510
Operating Revenue
4,038 4,202 4,472 4,914 5,163 5,339 6,319 6,848 6,833 6,510
Total Cost of Revenue
1,997 2,005 2,073 2,234 2,358 2,502 2,912 3,126 3,368 2,975
Operating Cost of Revenue
1,997 2,005 2,073 2,234 2,358 2,502 2,912 3,126 3,368 2,975
Total Operating Expenses
1,519 1,582 1,592 1,776 1,864 1,991 2,060 2,104 2,115 2,047
Selling, General & Admin Expense
1,189 1,253 1,251 1,389 1,460 1,496 1,619 1,637 1,634 1,568
Research & Development Expense
330 329 341 387 404 495 441 467 481 479
Total Other Income / (Expense), net
-42 -71 -4.00 42 -22 -4.00 13 -114 -11 33
Interest Expense
66 72 79 75 74 78 81 84 95 96
Interest & Investment Income
7.00 11 22 38 36 8.00 2.00 9.00 51 80
Other Income / (Expense), net
17 -10 53 79 16 66 92 -39 33 49
Income Tax Expense
42 82 119 630 -152 123 150 250 99 232
Basic Earnings per Share
$1.20 $1.42 $2.12 $0.98 $3.41 $2.33 $3.98 $4.19 $4.22 $4.44
Weighted Average Basic Shares Outstanding
333M 326M 322M 321M 314M 309M 304M 299M 294M 290M
Diluted Earnings per Share
$1.20 $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43
Weighted Average Diluted Shares Outstanding
335M 329M 326M 325M 318M 312M 307M 300M 296M 291M
Weighted Average Basic & Diluted Shares Outstanding
334.20M 325.40M 322.60M 322.40M 310.18M 306.85M 302.00M 296.07M 293.00M 285.60M
Cash Dividends to Common per Share
$0.40 $0.46 $0.53 $0.60 $0.66 $0.72 $0.78 $0.84 $0.90 $0.94

Quarterly Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Net Income / (Loss) Attributable to Common Shareholders
329 368 352 302 111 475 348 308 282 351 318
Consolidated Net Income / (Loss)
329 368 352 302 111 475 348 308 282 351 318
Net Income / (Loss) Continuing Operations
329 368 352 302 111 475 348 308 282 351 318
Total Pre-Tax Income
397 455 410 377 132 420 403 374 343 401 367
Total Operating Income
411 471 426 383 133 408 384 363 333 408 376
Total Gross Profit
939 1,012 968 924 658 915 908 856 855 916 899
Total Revenue
1,718 1,849 1,756 1,717 1,672 1,688 1,658 1,573 1,578 1,701 1,681
Operating Revenue
1,718 1,849 1,756 1,717 1,672 1,688 1,658 1,573 1,578 1,701 1,681
Total Cost of Revenue
779 837 788 793 1,014 773 750 717 723 785 782
Operating Cost of Revenue
779 837 788 793 1,014 773 750 717 723 785 782
Total Operating Expenses
528 541 542 541 525 507 524 493 522 508 523
Selling, General & Admin Expense
412 422 419 415 407 393 396 380 395 397 410
Research & Development Expense
116 119 123 126 118 114 128 113 127 111 113
Total Other Income / (Expense), net
-14 -16 -16 -6.00 -1.00 12 19 11 10 -7.00 -9.00
Interest Expense
19 23 25 24 24 22 22 20 22 32 28
Interest & Investment Income
2.00 5.00 9.00 12 13 17 18 19 19 24 15
Other Income / (Expense), net
3.00 2.00 0.00 6.00 10 17 23 12 13 1.00 4.00
Income Tax Expense
68 87 58 75 21 -55 55 66 61 50 49
Basic Earnings per Share
$1.10 $1.23 $1.19 $1.02 $0.38 $1.63 $1.19 $1.05 $0.97 $1.23 $1.12
Weighted Average Basic Shares Outstanding
298M 299M 296M 296M 294M 294M 293M 293M 290M 290M 285M
Diluted Earnings per Share
$1.10 $1.24 $1.19 $1.02 $0.38 $1.60 $1.18 $1.05 $0.97 $1.23 $1.11
Weighted Average Diluted Shares Outstanding
299M 300M 297M 297M 295M 296M 294M 293M 291M 291M 287M
Weighted Average Basic & Diluted Shares Outstanding
296.04M 296.07M 295.70M 295.38M 292.59M 293.00M 293.06M 291.76M 287.33M 285.60M 285.10M
Cash Dividends to Common per Share
$0.21 $0.21 $0.23 $0.23 $0.23 $0.23 $0.24 $0.24 $0.24 $0.24 $0.25

Annual Cash Flow Statements for Agilent Technologies

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-1,025 286 391 -432 -866 59 43 -434 537 -261
Net Cash From Operating Activities
512 793 889 1,087 1,021 921 1,485 1,312 1,772 1,751
Net Cash From Continuing Operating Activities
512 793 889 1,087 1,021 921 1,485 1,312 1,772 1,751
Net Income / (Loss) Continuing Operations
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Consolidated Net Income / (Loss)
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Depreciation Expense
253 246 212 210 238 308 321 317 271 257
Non-Cash Adjustments To Reconcile Net Income
103 112 91 106 97 191 63 236 432 186
Changes in Operating Assets and Liabilities, net
-245 -27 -98 455 -385 -297 -109 -495 -171 19
Net Cash From Investing Activities
-400 -238 -304 -705 -1,590 -147 -749 -338 -310 -1,258
Net Cash From Continuing Investing Activities
-400 -238 -304 -705 -1,590 -147 -749 -338 -310 -1,258
Purchase of Property, Plant & Equipment
-98 -139 -176 -177 -155 -119 -188 -291 -298 -378
Acquisitions
-75 -261 -128 -516 -1,409 0.00 -547 -52 -51 -862
Purchase of Investments
0.00 -80 -1.00 -11 -23 -20 -22 -13 - -5.00
Sale of Property, Plant & Equipment
12 0.00 0.00 1.00 0.00 1.00 1.00 0.00 4.00 0.00
Divestitures
3.00 0.00 2.00 - - - 0.00 0.00 50 0.00
Sale and/or Maturity of Investments
0.00 1.00 - - 0.00 0.00 12 22 5.00 0.00
Other Investing Activities, net
-242 241 -1.00 -2.00 -3.00 -9.00 -5.00 -4.00 -20 -13
Net Cash From Financing Activities
-1,089 -268 -202 -797 -299 -717 -696 -1,372 -930 -752
Net Cash From Continuing Financing Activities
-1,089 -268 -202 -797 -299 -717 -696 -1,372 -930 -749
Repayment of Debt
0.00 -294 -290 -693 -706 -1,766 -424 -609 -35 -609
Repurchase of Common Equity
-267 -434 -194 -422 -723 -469 -788 -1,139 -575 -1,150
Payment of Dividends
-133 -150 -170 -191 -210 -222 -236 -250 -265 -274
Issuance of Debt
0.00 554 400 483 1,302 1,717 773 635 0.00 1,237
Issuance of Common Equity
58 62 66 56 54 60 55 58 67 77
Other Financing Activities, net
-747 -6.00 -14 -30 -16 -37 -76 -67 -122 -30
Effect of Exchange Rate Changes
-48 -1.00 8.00 -17 2.00 2.00 3.00 -36 - -2.00
Cash Interest Paid
71 73 82 80 80 71 76 85 89 80
Cash Income Taxes Paid
129 67 63 102 159 361 211 279 199 314

Quarterly Cash Flow Statements for Agilent Technologies

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Net Change in Cash & Equivalents
-115 -17 197 -75 154 261 157 -76 108 -450 138
Net Cash From Operating Activities
326 448 296 398 562 516 485 333 452 481 431
Net Cash From Continuing Operating Activities
326 448 296 398 562 516 485 333 452 481 431
Net Income / (Loss) Continuing Operations
329 368 352 302 111 475 348 308 282 351 318
Consolidated Net Income / (Loss)
329 368 352 302 111 475 348 308 282 351 318
Depreciation Expense
80 73 67 71 71 62 62 63 63 69 72
Non-Cash Adjustments To Reconcile Net Income
42 42 62 37 319 14 54 44 42 46 49
Changes in Operating Assets and Liabilities, net
-125 -35 -185 -12 61 -35 21 -82 65 15 -8.00
Net Cash From Investing Activities
-73 -110 -104 -77 -89 -40 -95 -109 -100 -954 -94
Net Cash From Continuing Investing Activities
-73 -110 -104 -77 -89 -40 -95 -109 -100 -954 -94
Purchase of Property, Plant & Equipment
-82 -70 -76 -57 -81 -84 -90 -103 -92 -93 -97
Acquisitions
- -34 -30 -21 - - 0.00 - -3.00 -859 4.00
Other Investing Activities, net
- -3.00 -3.00 -2.00 -6.00 -9.00 -5.00 -3.00 -3.00 -2.00 -1.00
Net Cash From Financing Activities
-362 -341 -17 -390 -322 -201 -240 -291 -246 25 -180
Net Cash From Continuing Financing Activities
-362 -341 -17 -390 -322 -201 -240 -291 -246 28 -180
Repayment of Debt
-209 - 0.00 - - -35 -180 - - -429 -31
Repurchase of Common Equity
-323 -135 -75 -85 -335 -80 0.00 -230 -585 -335 -90
Payment of Dividends
-62 -62 -67 -66 -66 -66 -69 -69 -68 -68 -71
Issuance of Debt
205 -145 203 -238 55 -20 0.00 - 375 862 4.00
Issuance of Common Equity
28 3.00 35 - 30 2.00 34 9.00 33 1.00 30
Other Financing Activities, net
-1.00 -2.00 -113 -1.00 -6.00 -2.00 -25 -1.00 -1.00 -3.00 -22
Other Net Changes in Cash
- - - - - - 7.00 - - - -19
Cash Interest Paid
16 29 15 29 16 29 14 26 10 30 3.00
Cash Income Taxes Paid
83 62 17 111 15 56 24 200 60 30 19

Annual Balance Sheets for Agilent Technologies

This table presents Agilent Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
7,479 7,794 8,426 8,541 9,452 9,627 10,705 10,532 10,763 11,846
Total Current Assets
3,686 3,635 4,169 3,848 3,189 3,415 3,799 3,778 4,186 3,959
Cash & Equivalents
2,003 2,289 2,678 2,247 1,382 1,441 1,484 1,053 1,590 1,329
Accounts Receivable
606 631 724 776 930 1,038 1,172 1,405 1,291 1,324
Inventories, net
541 533 575 638 679 720 830 1,038 1,031 972
Other Current Assets
294 182 192 187 198 216 222 282 274 334
Plant, Property, & Equipment, net
604 639 757 822 850 845 945 1,100 1,270 1,778
Total Noncurrent Assets
3,189 3,520 3,500 3,871 5,413 5,367 5,961 5,654 5,307 6,109
Long-Term Investments
86 135 138 68 102 158 185 195 164 175
Goodwill
2,366 2,517 2,607 2,973 3,593 3,602 3,975 3,952 3,960 4,477
Intangible Assets
445 416 361 491 1,107 831 981 821 475 547
Other Noncurrent Operating Assets
292 452 394 339 611 776 820 686 708 910
Total Liabilities & Shareholders' Equity
7,479 7,794 8,426 8,541 9,452 9,627 10,705 10,532 10,763 11,846
Total Liabilities
3,309 3,548 3,591 3,970 4,704 4,754 5,316 5,227 4,918 5,948
Total Current Liabilities
976 945 1,263 1,171 2,080 1,467 1,708 1,861 1,603 1,895
Short-Term Debt
- 0.00 210 0.00 616 75 0.00 36 0.00 45
Accounts Payable
279 257 305 340 354 354 446 580 418 540
Accrued Expenses
- - - - - - - - - 398
Current Deferred Revenue
258 269 291 324 336 386 441 461 505 544
Current Employee Benefit Liabilities
221 235 276 304 334 367 493 455 371 368
Total Noncurrent Liabilities
2,333 2,603 2,328 2,799 2,624 3,287 3,608 3,366 3,315 4,053
Long-Term Debt
1,655 1,904 1,801 1,799 1,791 2,284 2,729 2,733 2,735 3,345
Noncurrent Employee Benefit Liabilities
264 360 234 239 360 389 220 97 103 130
Other Noncurrent Operating Liabilities
414 339 293 761 473 614 659 536 477 578
Commitments & Contingencies
- - - - 0.00 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,170 4,246 4,835 4,571 4,748 4,873 5,389 5,305 5,845 5,898
Total Preferred & Common Equity
4,167 4,243 4,831 4,567 4,748 4,873 5,389 5,305 5,845 5,898
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,167 4,243 4,831 4,567 4,748 4,873 5,389 5,305 5,845 5,898
Common Stock
9,051 9,165 5,303 5,311 5,280 5,314 5,323 5,328 5,390 5,453
Retained Earnings
5,581 6,089 -126 -336 -18 81 348 324 782 750
Accumulated Other Comprehensive Income / (Loss)
-391 -503 -346 -408 -514 -522 -282 -347 -327 -305

Quarterly Balance Sheets for Agilent Technologies

This table presents Agilent Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Total Assets
10,484 10,532 10,919 10,792 10,675 10,763 10,948 10,856 10,996 11,846 11,914
Total Current Assets
3,690 3,778 4,078 3,949 4,030 4,186 4,338 4,203 4,256 3,959 4,107
Cash & Equivalents
1,071 1,053 1,250 1,175 1,329 1,590 1,748 1,671 1,779 1,329 1,467
Accounts Receivable
1,345 1,405 1,459 1,401 1,339 1,291 1,295 1,249 1,227 1,324 1,328
Inventories, net
1,010 1,038 1,111 1,103 1,072 1,031 1,033 1,000 978 972 997
Other Current Assets
258 282 258 270 290 274 262 283 272 334 315
Plant, Property, & Equipment, net
1,054 1,100 1,147 1,184 1,211 1,270 1,314 1,371 1,446 1,778 1,816
Total Noncurrent Assets
5,740 5,654 5,694 5,659 5,434 5,307 5,296 5,282 5,294 6,109 5,991
Long-Term Investments
194 195 188 186 190 164 170 177 186 175 173
Goodwill
3,948 3,952 3,983 3,980 3,984 3,960 3,967 3,963 3,965 4,477 4,429
Intangible Assets
849 821 810 798 502 475 443 417 392 547 514
Other Noncurrent Operating Assets
749 686 713 695 758 708 716 725 751 910 875
Total Liabilities & Shareholders' Equity
10,484 10,532 10,919 10,792 10,675 10,763 10,948 10,856 10,996 11,846 11,914
Total Liabilities
5,393 5,227 5,310 5,011 5,117 4,918 4,760 4,642 5,093 5,948 5,887
Total Current Liabilities
1,902 1,861 1,936 1,666 1,760 1,603 1,617 1,958 2,389 1,895 1,869
Short-Term Debt
180 36 238 0.00 55 0.00 - 420 795 45 16
Accounts Payable
558 580 540 479 452 418 488 461 497 540 547
Accrued Expenses
277 - 341 309 410 - 335 218 264 398 436
Current Deferred Revenue
498 461 521 519 512 505 522 533 524 544 612
Current Employee Benefit Liabilities
389 455 296 359 331 371 272 326 309 368 258
Total Noncurrent Liabilities
3,491 3,366 3,374 3,345 3,357 3,315 3,143 2,684 2,704 4,053 4,018
Long-Term Debt
2,732 2,733 2,733 2,733 2,734 2,735 2,555 2,136 2,137 3,345 3,347
Noncurrent Employee Benefit Liabilities
176 97 99 97 92 103 102 99 96 130 120
Other Noncurrent Operating Liabilities
583 536 542 515 531 477 486 449 471 578 551
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,091 5,305 5,609 5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027
Total Preferred & Common Equity
5,091 5,305 5,609 5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,091 5,305 5,609 5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027
Common Stock
5,314 5,328 5,348 5,363 5,385 5,390 5,443 5,461 5,461 5,453 5,492
Retained Earnings
139 324 541 700 444 782 1,061 1,090 773 750 916
Accumulated Other Comprehensive Income / (Loss)
-362 -347 -280 -282 -271 -327 -316 -337 -331 -305 -381

Annual Metrics and Ratios for Agilent Technologies

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-0.25% 4.06% 6.43% 9.88% 5.07% 3.41% 18.36% 8.37% -0.22% -4.73%
EBITDA Growth
14.45% 7.45% 25.97% 11.29% 0.17% 2.09% 44.26% 7.73% -12.76% 8.46%
EBIT Growth
63.33% 12.24% 42.15% 14.30% -2.65% -4.70% 57.79% 9.73% -12.41% 11.14%
NOPAT Growth
12.21% 9.65% 31.61% -56.07% 263.16% -34.12% 65.89% 12.57% -7.33% 0.87%
Net Income Growth
-26.96% 15.21% 48.05% -53.80% 238.92% -32.87% 68.29% 3.64% -1.12% 3.95%
EPS Growth
-25.93% 16.67% 50.00% -53.81% 247.42% -31.75% 71.30% 6.09% 0.24% 5.73%
Operating Cash Flow Growth
-29.96% 54.88% 12.11% 22.27% -6.07% -9.79% 61.24% -11.65% 35.06% -1.19%
Free Cash Flow Firm Growth
-62.10% -59.07% 32.07% -27.76% -287.52% 246.41% -37.74% 86.10% 41.90% -75.76%
Invested Capital Growth
-6.25% 6.64% 8.16% 0.62% 39.85% -0.67% 12.87% 7.36% 0.00% 14.03%
Revenue Q/Q Growth
-0.20% 1.84% 1.78% 2.18% 1.43% 2.22% 2.88% 2.84% -2.30% 0.20%
EBITDA Q/Q Growth
18.92% 0.59% 6.77% 1.45% 1.19% 4.72% 11.04% -0.32% -3.44% -0.50%
EBIT Q/Q Growth
41.84% 1.51% 9.14% 1.34% -0.62% 6.42% 13.13% 0.32% -3.35% -1.03%
NOPAT Q/Q Growth
12.46% 0.02% -0.05% 9.47% 1.97% 3.63% 15.64% -1.38% 7.30% -7.64%
Net Income Q/Q Growth
21.88% -2.94% 8.06% 6.04% -0.09% 4.05% 22.22% -5.57% 9.44% -8.78%
EPS Q/Q Growth
21.21% -4.11% 6.60% 6.59% 0.90% 3.60% 23.13% -4.78% 9.40% -7.71%
Operating Cash Flow Q/Q Growth
12.53% -0.88% 6.47% 8.37% -5.38% 7.34% 4.50% 0.54% 3.99% -1.96%
Free Cash Flow Firm Q/Q Growth
-66.64% 20.37% -33.29% 171.96% -192.67% 281.10% -28.53% 9.05% 16.93% -77.10%
Invested Capital Q/Q Growth
-2.89% -3.94% 0.95% -2.66% 21.15% -2.85% 3.01% 1.40% -0.03% 13.30%
Profitability Metrics
- - - - - - - - - -
Gross Margin
50.54% 52.28% 53.64% 54.54% 54.33% 53.14% 53.92% 54.35% 50.71% 54.30%
EBITDA Margin
19.61% 20.25% 23.97% 24.28% 23.15% 22.85% 27.85% 27.69% 24.21% 27.56%
Operating Margin
12.93% 14.64% 18.05% 18.40% 18.23% 15.85% 21.32% 23.63% 19.76% 22.86%
EBIT Margin
13.35% 14.40% 19.23% 20.00% 18.54% 17.08% 22.77% 23.06% 20.24% 23.61%
Profit (Net Income) Margin
9.93% 10.99% 15.30% 6.43% 20.74% 13.47% 19.15% 18.31% 18.15% 19.80%
Tax Burden Percent
83.54% 84.93% 85.18% 33.40% 116.54% 85.39% 88.97% 83.38% 92.61% 84.75%
Interest Burden Percent
89.05% 89.92% 93.37% 96.24% 96.03% 92.32% 94.51% 95.25% 96.82% 98.96%
Effective Tax Rate
8.75% 15.07% 14.82% 66.60% -16.54% 14.61% 11.03% 16.62% 7.39% 15.25%
Return on Invested Capital (ROIC)
13.19% 14.47% 17.73% 7.47% 22.55% 12.78% 19.99% 20.47% 18.32% 17.26%
ROIC Less NNEP Spread (ROIC-NNEP)
19.88% 24.55% 18.24% 5.35% 9.95% 12.38% 21.33% 12.83% 17.50% 19.21%
Return on Net Nonoperating Assets (RNNOA)
-4.73% -3.49% -2.66% -0.75% 0.43% 2.16% 3.59% 2.99% 3.93% 4.69%
Return on Equity (ROE)
8.47% 10.98% 15.06% 6.72% 22.99% 14.95% 23.58% 23.45% 22.24% 21.95%
Cash Return on Invested Capital (CROIC)
19.65% 8.04% 9.89% 6.85% -10.68% 13.45% 7.90% 13.37% 18.32% 4.15%
Operating Return on Assets (OROA)
5.89% 7.92% 10.60% 11.59% 10.64% 9.56% 14.16% 14.87% 12.99% 13.60%
Return on Assets (ROA)
4.38% 6.05% 8.43% 3.72% 11.90% 7.54% 11.90% 11.81% 11.65% 11.40%
Return on Common Equity (ROCE)
8.46% 10.97% 15.05% 6.71% 22.98% 14.95% 23.58% 23.45% 22.24% 21.95%
Return on Equity Simple (ROE_SIMPLE)
9.62% 10.89% 14.16% 6.92% 22.56% 14.75% 22.45% 23.64% 21.21% 21.85%
Net Operating Profit after Tax (NOPAT)
476 522 687 302 1,097 722 1,198 1,349 1,250 1,261
NOPAT Margin
11.80% 12.43% 15.37% 6.15% 21.24% 13.53% 18.97% 19.70% 18.30% 19.37%
Net Nonoperating Expense Percent (NNEP)
-6.69% -10.08% -0.51% 2.12% 12.60% 0.41% -1.34% 7.63% 0.81% -1.95%
Return On Investment Capital (ROIC_SIMPLE)
8.18% 8.49% 10.04% 4.74% 15.33% 9.99% 14.76% 16.71% 14.57% 13.58%
Cost of Revenue to Revenue
49.46% 47.72% 46.36% 45.46% 45.67% 46.86% 46.08% 45.65% 49.29% 45.70%
SG&A Expenses to Revenue
29.45% 29.82% 27.97% 28.27% 28.28% 28.02% 25.62% 23.90% 23.91% 24.09%
R&D to Revenue
8.17% 7.83% 7.63% 7.88% 7.82% 9.27% 6.98% 6.82% 7.04% 7.36%
Operating Expenses to Revenue
37.62% 37.65% 35.60% 36.14% 36.10% 37.29% 32.60% 30.72% 30.95% 31.44%
Earnings before Interest and Taxes (EBIT)
539 605 860 983 957 912 1,439 1,579 1,383 1,537
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
792 851 1,072 1,193 1,195 1,220 1,760 1,896 1,654 1,794
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.79 3.13 4.29 4.32 4.76 6.28 8.65 7.60 5.13 6.34
Price to Tangible Book Value (P/TBV)
8.57 10.12 11.13 17.90 470.97 69.58 107.71 75.79 21.27 42.76
Price to Revenue (P/Rev)
2.88 3.16 4.64 4.02 4.38 5.73 7.38 5.89 4.39 5.74
Price to Earnings (P/E)
28.97 28.70 30.32 62.47 21.11 42.58 38.54 32.15 24.18 28.99
Dividend Yield
1.14% 1.13% 0.82% 0.96% 0.90% 0.73% 0.50% 0.62% 0.88% 0.73%
Earnings Yield
3.45% 3.48% 3.30% 1.60% 4.74% 2.35% 2.59% 3.11% 4.14% 3.45%
Enterprise Value to Invested Capital (EV/IC)
3.13 3.42 4.95 4.74 4.15 5.57 7.49 6.13 4.54 5.04
Enterprise Value to Revenue (EV/Rev)
2.71 3.03 4.46 3.91 4.56 5.88 7.53 6.11 4.53 6.03
Enterprise Value to EBITDA (EV/EBITDA)
13.82 14.97 18.60 16.12 19.69 25.72 27.05 22.07 18.72 21.88
Enterprise Value to EBIT (EV/EBIT)
20.30 21.06 23.19 19.56 24.59 34.40 33.08 26.50 22.39 25.54
Enterprise Value to NOPAT (EV/NOPAT)
22.97 24.40 29.01 63.68 21.46 43.43 39.72 31.02 24.77 31.13
Enterprise Value to Operating Cash Flow (EV/OCF)
21.37 16.07 22.43 17.69 23.05 34.07 32.06 31.89 17.48 22.42
Enterprise Value to Free Cash Flow (EV/FCFF)
15.43 43.90 52.01 69.43 0.00 41.26 100.55 47.49 24.77 129.55
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.40 0.45 0.42 0.39 0.51 0.48 0.51 0.52 0.47 0.57
Long-Term Debt to Equity
0.40 0.45 0.37 0.39 0.38 0.47 0.51 0.52 0.47 0.57
Financial Leverage
-0.24 -0.14 -0.15 -0.14 0.04 0.17 0.17 0.23 0.22 0.24
Leverage Ratio
1.93 1.81 1.79 1.80 1.93 1.98 1.98 1.99 1.91 1.93
Compound Leverage Factor
1.72 1.63 1.67 1.74 1.85 1.83 1.87 1.89 1.85 1.91
Debt to Total Capital
28.41% 30.96% 29.37% 28.24% 33.64% 32.62% 33.62% 34.30% 31.88% 36.50%
Short-Term Debt to Total Capital
0.00% 0.00% 3.07% 0.00% 8.61% 1.04% 0.00% 0.45% 0.00% 0.48%
Long-Term Debt to Total Capital
28.41% 30.96% 26.31% 28.24% 25.03% 31.58% 33.62% 33.85% 31.88% 36.01%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.05% 0.05% 0.06% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
71.54% 68.99% 70.57% 71.70% 66.36% 67.38% 66.38% 65.70% 68.12% 63.50%
Debt to EBITDA
2.09 2.24 1.88 1.51 2.01 1.93 1.55 1.46 1.65 1.89
Net Debt to EBITDA
-0.85 -0.61 -0.75 -0.43 0.77 0.62 0.55 0.80 0.59 1.05
Long-Term Debt to EBITDA
2.09 2.24 1.68 1.51 1.50 1.87 1.55 1.44 1.65 1.86
Debt to NOPAT
3.47 3.65 2.93 5.96 2.19 3.27 2.28 2.05 2.19 2.69
Net Debt to NOPAT
-1.42 -1.00 -1.17 -1.71 0.84 1.05 0.81 1.13 0.78 1.50
Long-Term Debt to NOPAT
3.47 3.65 2.62 5.96 1.63 3.16 2.28 2.03 2.19 2.65
Altman Z-Score
4.36 4.55 4.73 4.26 3.90 4.99 6.58 6.03 5.11 5.05
Noncontrolling Interest Sharing Ratio
0.06% 0.07% 0.08% 0.09% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
3.78 3.85 3.30 3.29 1.53 2.33 2.22 2.03 2.61 2.09
Quick Ratio
2.67 3.09 2.69 2.58 1.11 1.69 1.61 1.32 1.80 1.40
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
709 290 383 277 -519 760 473 881 1,250 303
Operating Cash Flow to CapEx
595.35% 570.50% 505.11% 617.61% 658.71% 780.51% 794.12% 450.86% 602.72% 463.23%
Free Cash Flow to Firm to Interest Expense
10.75 4.03 4.85 3.69 -7.02 9.75 5.84 10.49 13.16 3.16
Operating Cash Flow to Interest Expense
7.76 11.01 11.25 14.49 13.80 11.81 18.33 15.62 18.65 18.24
Operating Cash Flow Less CapEx to Interest Expense
6.45 9.08 9.03 12.15 11.70 10.29 16.02 12.15 15.56 14.30
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.44 0.55 0.55 0.58 0.57 0.56 0.62 0.64 0.64 0.58
Accounts Receivable Turnover
6.56 6.79 6.60 6.55 6.05 5.43 5.72 5.31 5.07 4.98
Inventory Turnover
3.58 3.73 3.74 3.68 3.58 3.58 3.76 3.35 3.26 2.97
Fixed Asset Turnover
6.54 6.76 6.41 6.22 6.18 6.30 7.06 6.70 5.77 4.27
Accounts Payable Turnover
6.87 7.48 7.38 6.93 6.80 7.07 7.28 6.09 6.75 6.21
Days Sales Outstanding (DSO)
55.68 53.73 55.30 55.71 60.30 67.27 63.83 68.68 72.01 73.31
Days Inventory Outstanding (DIO)
101.90 97.76 97.54 99.09 101.93 102.05 97.14 109.06 112.11 122.87
Days Payable Outstanding (DPO)
53.10 48.79 49.48 52.69 53.71 51.64 50.14 59.90 54.08 58.77
Cash Conversion Cycle (CCC)
104.48 102.70 103.36 102.11 108.52 117.67 110.83 117.83 130.04 137.41
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
3,494 3,726 4,030 4,055 5,671 5,633 6,358 6,826 6,826 7,784
Invested Capital Turnover
1.12 1.16 1.15 1.22 1.06 0.94 1.05 1.04 1.00 0.89
Increase / (Decrease) in Invested Capital
-233 232 304 25 1,616 -38 725 468 0.00 958
Enterprise Value (EV)
10,942 12,743 19,939 19,229 23,530 31,374 47,606 41,842 30,967 39,259
Market Capitalization
11,615 13,260 20,740 19,741 22,607 30,614 46,637 40,321 29,986 37,373
Book Value per Share
$12.57 $13.08 $15.01 $14.33 $15.34 $15.81 $17.80 $17.92 $19.98 $20.53
Tangible Book Value per Share
$4.09 $4.04 $5.79 $3.46 $0.16 $1.43 $1.43 $1.80 $4.82 $3.04
Total Capital
5,825 6,150 6,846 6,370 7,155 7,232 8,118 8,074 8,580 9,288
Total Debt
1,655 1,904 2,011 1,799 2,407 2,359 2,729 2,769 2,735 3,390
Total Long-Term Debt
1,655 1,904 1,801 1,799 1,791 2,284 2,729 2,733 2,735 3,345
Net Debt
-676 -520 -805 -516 923 760 969 1,521 981 1,886
Capital Expenditures (CapEx)
86 139 176 176 155 118 187 291 294 378
Debt-free, Cash-free Net Working Capital (DFCFNWC)
465 401 438 430 343 582 516 900 993 780
Debt-free Net Working Capital (DFNWC)
2,710 2,690 3,116 2,677 1,725 2,023 2,091 1,953 2,583 2,109
Net Working Capital (NWC)
2,710 2,690 2,906 2,677 1,109 1,948 2,091 1,917 2,583 2,064
Net Nonoperating Expense (NNE)
75 60 3.41 -14 26 3.42 -12 95 10 -28
Net Nonoperating Obligations (NNO)
-676 -520 -805 -516 923 760 969 1,521 981 1,886
Total Depreciation and Amortization (D&A)
253 246 212 210 238 308 321 317 271 257
Debt-free, Cash-free Net Working Capital to Revenue
11.52% 9.54% 9.79% 8.75% 6.64% 10.90% 8.17% 13.14% 14.53% 11.98%
Debt-free Net Working Capital to Revenue
67.11% 64.02% 69.68% 54.48% 33.41% 37.89% 33.09% 28.52% 37.80% 32.40%
Net Working Capital to Revenue
67.11% 64.02% 64.98% 54.48% 21.48% 36.49% 33.09% 27.99% 37.80% 31.71%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$1.20 $1.42 $2.12 $0.98 $3.41 $2.33 $3.98 $4.19 $4.22 $4.44
Adjusted Weighted Average Basic Shares Outstanding
333M 326M 322M 321M 314M 309M 304M 299M 294M 290M
Adjusted Diluted Earnings per Share
$1.20 $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43
Adjusted Weighted Average Diluted Shares Outstanding
335M 329M 326M 325M 318M 312M 307M 300M 296M 291M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.41 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
332.17M 321.75M 323.02M 318.53M 310.18M 306.85M 302.00M 296.07M 293.00M 285.60M
Normalized Net Operating Profit after Tax (NOPAT)
476 522 687 633 659 722 1,198 1,349 1,250 1,261
Normalized NOPAT Margin
11.80% 12.43% 15.37% 12.88% 12.76% 13.53% 18.97% 19.70% 18.30% 19.37%
Pre Tax Income Margin
11.89% 12.95% 17.96% 19.25% 17.80% 15.77% 21.52% 21.96% 19.60% 23.36%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
8.17 8.40 10.89 13.11 12.93 11.69 17.77 18.80 14.56 16.01
NOPAT to Interest Expense
7.22 7.25 8.70 4.03 14.82 9.26 14.80 16.06 13.16 13.14
EBIT Less CapEx to Interest Expense
6.86 6.47 8.66 10.76 10.84 10.18 15.46 15.33 11.46 12.07
NOPAT Less CapEx to Interest Expense
5.91 5.32 6.47 1.68 12.72 7.75 12.49 12.60 10.07 9.20
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
33.17% 32.47% 24.85% 60.44% 19.61% 30.88% 19.50% 19.94% 21.37% 21.26%
Augmented Payout Ratio
99.75% 126.41% 53.22% 193.99% 87.11% 96.11% 84.63% 110.77% 67.74% 110.47%

Quarterly Metrics and Ratios for Agilent Technologies

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
8.32% 11.39% 4.90% 6.85% -2.68% -8.71% -5.58% -8.39% -5.62% 0.77% 1.39%
EBITDA Growth
14.35% -1.09% 17.10% 5.75% -56.68% -10.81% -4.87% -4.78% 91.12% -1.85% -3.62%
EBIT Growth
18.97% 1.07% 25.66% 10.20% -65.46% -10.15% -4.46% -3.60% 141.96% -3.76% -6.63%
NOPAT Growth
25.56% -2.25% 9.64% 3.58% -67.16% 21.13% -9.34% -2.56% 144.79% -22.60% -1.75%
Net Income Growth
24.62% -16.74% 24.38% 10.22% -66.26% 29.08% -1.14% 1.99% 154.05% -26.11% -8.62%
EPS Growth
27.91% -14.48% 27.96% 12.09% -65.45% 29.03% -0.84% 2.94% 155.26% -23.13% -5.93%
Operating Cash Flow Growth
-2.40% 1.59% 16.08% 40.64% 72.39% 15.18% 63.85% -16.33% -19.57% -6.78% -11.13%
Free Cash Flow Firm Growth
-113.56% 74.03% 38.52% -35.30% 107.22% 630.02% 368.83% 345.12% 1,363.16% -230.22% -192.38%
Invested Capital Growth
9.07% 7.36% 9.29% 7.89% 1.43% 0.00% -4.44% -3.23% 0.62% 14.03% 13.55%
Revenue Q/Q Growth
6.91% 7.63% -5.03% -2.22% -2.62% 0.96% -1.78% -5.13% 0.32% 7.79% -1.18%
EBITDA Q/Q Growth
13.56% 10.53% -9.71% -6.69% -53.48% 127.57% -3.70% -6.61% -6.62% 16.87% -5.44%
EBIT Q/Q Growth
17.28% 14.25% -9.94% -8.69% -63.24% 197.20% -4.24% -7.86% -7.73% 18.21% -7.09%
NOPAT Q/Q Growth
14.98% 11.84% -3.99% -16.11% -63.55% 312.58% -28.14% -9.85% -8.42% 30.44% -8.77%
Net Income Q/Q Growth
20.07% 11.85% -4.35% -14.20% -63.25% 327.93% -26.74% -11.49% -8.44% 24.47% -9.40%
EPS Q/Q Growth
20.88% 12.73% -4.03% -14.29% -62.75% 321.05% -26.25% -11.02% -7.62% 26.80% -9.76%
Operating Cash Flow Q/Q Growth
15.19% 37.42% -33.93% 34.46% 41.21% -8.19% -6.01% -31.34% 35.74% 6.42% -10.40%
Free Cash Flow Firm Q/Q Growth
-37.31% 60.32% -177.13% 10.39% 107.33% 2,812.89% 40.56% -18.29% -56.26% -359.24% 0.28%
Invested Capital Q/Q Growth
1.54% 1.40% 4.63% 0.15% -4.54% -0.03% -0.01% 1.42% -0.75% 13.30% -0.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
54.66% 54.73% 55.13% 53.81% 39.35% 54.21% 54.76% 54.42% 54.18% 53.85% 53.48%
EBITDA Margin
28.75% 29.53% 28.08% 26.79% 12.80% 28.85% 28.29% 27.84% 25.92% 28.10% 26.89%
Operating Margin
23.92% 25.47% 24.26% 22.31% 7.95% 24.17% 23.16% 23.08% 21.10% 23.99% 22.37%
EBIT Margin
24.10% 25.58% 24.26% 22.66% 8.55% 25.18% 24.55% 23.84% 21.93% 24.04% 22.61%
Profit (Net Income) Margin
19.15% 19.90% 20.05% 17.59% 6.64% 28.14% 20.99% 19.58% 17.87% 20.63% 18.92%
Tax Burden Percent
82.87% 80.88% 85.85% 80.11% 84.09% 113.10% 86.35% 82.35% 82.22% 87.53% 86.65%
Interest Burden Percent
95.89% 96.19% 96.24% 96.92% 92.31% 98.82% 99.02% 99.73% 99.13% 98.04% 96.58%
Effective Tax Rate
17.13% 19.12% 14.15% 19.89% 15.91% -13.10% 13.65% 17.65% 17.78% 12.47% 13.35%
Return on Invested Capital (ROIC)
20.46% 21.40% 21.11% 18.25% 6.90% 27.36% 19.29% 17.80% 16.46% 18.71% 17.37%
ROIC Less NNEP Spread (ROIC-NNEP)
19.65% 20.36% 20.16% 17.92% 6.84% 28.45% 20.80% 18.67% 17.19% 18.28% 16.71%
Return on Net Nonoperating Assets (RNNOA)
5.61% 4.74% 5.46% 4.73% 1.87% 6.38% 3.83% 3.24% 3.36% 4.46% 3.23%
Return on Equity (ROE)
26.08% 26.14% 26.57% 22.99% 8.77% 33.75% 23.11% 21.04% 19.81% 23.17% 20.60%
Cash Return on Invested Capital (CROIC)
12.52% 13.37% 11.36% 12.64% 15.77% 18.32% 21.92% 20.39% 19.32% 4.15% 4.53%
Operating Return on Assets (OROA)
15.30% 16.50% 15.83% 15.01% 5.65% 16.16% 15.12% 14.52% 13.15% 13.85% 12.92%
Return on Assets (ROA)
12.16% 12.84% 13.08% 11.66% 4.39% 18.06% 12.93% 11.92% 10.72% 11.88% 10.81%
Return on Common Equity (ROCE)
26.08% 26.14% 26.57% 22.99% 8.77% 33.75% 23.11% 21.04% 19.81% 23.17% 20.60%
Return on Equity Simple (ROE_SIMPLE)
26.09% 0.00% 23.59% 23.37% 20.39% 0.00% 19.97% 19.99% 23.94% 0.00% 20.89%
Net Operating Profit after Tax (NOPAT)
341 381 366 307 112 461 332 299 274 357 326
NOPAT Margin
19.83% 20.60% 20.83% 17.87% 6.69% 27.34% 20.00% 19.00% 17.35% 21.00% 19.38%
Net Nonoperating Expense Percent (NNEP)
0.81% 1.04% 0.94% 0.33% 0.06% -1.08% -1.51% -0.87% -0.74% 0.43% 0.66%
Return On Investment Capital (ROIC_SIMPLE)
4.26% 4.72% 4.26% 3.60% 1.34% 5.38% 3.79% 3.41% 3.10% 3.85% 3.47%
Cost of Revenue to Revenue
45.34% 45.27% 44.87% 46.19% 60.65% 45.79% 45.24% 45.58% 45.82% 46.15% 46.52%
SG&A Expenses to Revenue
23.98% 22.82% 23.86% 24.17% 24.34% 23.28% 23.88% 24.16% 25.03% 23.34% 24.39%
R&D to Revenue
6.75% 6.44% 7.00% 7.34% 7.06% 6.75% 7.72% 7.18% 8.05% 6.53% 6.72%
Operating Expenses to Revenue
30.73% 29.26% 30.87% 31.51% 31.40% 30.04% 31.60% 31.34% 33.08% 29.86% 31.11%
Earnings before Interest and Taxes (EBIT)
414 473 426 389 143 425 407 375 346 409 380
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
494 546 493 460 214 487 469 438 409 478 452
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.73 7.60 7.91 6.84 6.40 5.13 6.11 6.43 6.96 6.34 7.16
Price to Tangible Book Value (P/TBV)
133.90 75.79 54.40 39.43 33.20 21.27 21.26 21.78 26.59 42.76 39.84
Price to Revenue (P/Rev)
5.91 5.89 6.41 5.62 5.09 4.39 5.61 6.06 6.33 5.74 6.61
Price to Earnings (P/E)
29.64 32.15 33.56 29.27 31.41 24.18 30.59 32.16 29.10 28.99 34.30
Dividend Yield
0.63% 0.62% 0.57% 0.65% 0.73% 0.88% 0.71% 0.68% 0.66% 0.73% 0.63%
Earnings Yield
3.37% 3.11% 2.98% 3.42% 3.18% 4.14% 3.27% 3.11% 3.44% 3.45% 2.92%
Enterprise Value to Invested Capital (EV/IC)
6.09 6.13 6.43 5.72 5.40 4.54 5.63 5.87 6.13 5.04 5.79
Enterprise Value to Revenue (EV/Rev)
6.16 6.11 6.63 5.81 5.27 4.53 5.71 6.17 6.48 6.03 6.87
Enterprise Value to EBITDA (EV/EBITDA)
21.56 22.07 23.34 20.53 21.52 18.72 23.58 25.28 23.34 21.88 25.27
Enterprise Value to EBIT (EV/EBIT)
26.05 26.50 27.57 24.04 25.76 22.39 28.18 30.12 27.10 25.54 29.74
Enterprise Value to NOPAT (EV/NOPAT)
29.98 31.02 33.19 29.36 31.63 24.77 31.67 33.78 30.82 31.13 35.79
Enterprise Value to Operating Cash Flow (EV/OCF)
31.42 31.89 33.94 27.87 21.63 17.48 19.60 21.44 23.56 22.42 26.46
Enterprise Value to Free Cash Flow (EV/FCFF)
50.76 47.49 59.14 46.99 34.47 24.77 25.11 28.34 31.80 129.55 136.17
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.57 0.52 0.53 0.47 0.50 0.47 0.41 0.41 0.50 0.57 0.56
Long-Term Debt to Equity
0.54 0.52 0.49 0.47 0.49 0.47 0.41 0.34 0.36 0.57 0.56
Financial Leverage
0.29 0.23 0.27 0.26 0.27 0.22 0.18 0.17 0.20 0.24 0.19
Leverage Ratio
2.09 1.99 1.97 1.95 1.99 1.91 1.85 1.80 1.89 1.93 1.87
Compound Leverage Factor
2.00 1.91 1.90 1.89 1.83 1.89 1.84 1.80 1.87 1.89 1.81
Debt to Total Capital
36.39% 34.30% 34.63% 32.10% 33.41% 31.88% 29.22% 29.14% 33.19% 36.50% 35.81%
Short-Term Debt to Total Capital
2.25% 0.45% 2.77% 0.00% 0.66% 0.00% 0.00% 4.79% 9.00% 0.48% 0.17%
Long-Term Debt to Total Capital
34.14% 33.85% 31.85% 32.10% 32.75% 31.88% 29.22% 24.36% 24.19% 36.01% 35.64%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
63.61% 65.70% 65.37% 67.90% 66.59% 68.12% 70.78% 70.86% 66.81% 63.50% 64.19%
Debt to EBITDA
1.53 1.46 1.51 1.37 1.63 1.65 1.57 1.59 1.63 1.89 1.89
Net Debt to EBITDA
0.86 0.80 0.78 0.69 0.74 0.59 0.39 0.44 0.54 1.05 0.97
Long-Term Debt to EBITDA
1.44 1.44 1.39 1.37 1.60 1.65 1.57 1.33 1.19 1.86 1.88
Debt to NOPAT
2.13 2.05 2.15 1.96 2.39 2.19 2.11 2.12 2.15 2.69 2.68
Net Debt to NOPAT
1.20 1.13 1.11 0.98 1.09 0.78 0.52 0.59 0.71 1.50 1.37
Long-Term Debt to NOPAT
2.00 2.03 1.98 1.96 2.35 2.19 2.11 1.77 1.57 2.65 2.67
Altman Z-Score
5.37 5.69 6.08 5.85 5.19 4.81 5.94 6.27 5.84 4.73 5.39
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.94 2.03 2.11 2.37 2.29 2.61 2.68 2.15 1.78 2.09 2.20
Quick Ratio
1.27 1.32 1.40 1.55 1.52 1.80 1.88 1.49 1.26 1.40 1.50
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-219 -87 -241 -216 16 461 649 530 232 -601 -599
Operating Cash Flow to CapEx
397.56% 640.00% 389.47% 698.25% 693.83% 614.29% 538.89% 323.30% 491.30% 517.20% 444.33%
Free Cash Flow to Firm to Interest Expense
-11.55 -3.79 -9.65 -9.01 0.66 20.97 29.48 26.50 10.54 -18.78 -21.40
Operating Cash Flow to Interest Expense
17.16 19.48 11.84 16.58 23.42 23.45 22.05 16.65 20.55 15.03 15.39
Operating Cash Flow Less CapEx to Interest Expense
12.84 16.43 8.80 14.21 20.04 19.64 17.95 11.50 16.36 12.13 11.93
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.63 0.64 0.65 0.66 0.66 0.64 0.62 0.61 0.60 0.58 0.57
Accounts Receivable Turnover
5.40 5.31 5.20 5.34 5.21 5.07 4.89 4.97 5.06 4.98 4.98
Inventory Turnover
3.34 3.35 3.17 3.13 3.30 3.26 3.11 3.09 2.89 2.97 2.96
Fixed Asset Turnover
6.80 6.70 6.53 6.42 6.18 5.77 5.47 5.16 4.89 4.27 4.17
Accounts Payable Turnover
6.26 6.09 6.21 6.51 6.80 6.75 6.48 6.92 6.24 6.21 5.81
Days Sales Outstanding (DSO)
67.61 68.68 70.16 68.39 70.04 72.01 74.63 73.38 72.08 73.31 73.27
Days Inventory Outstanding (DIO)
109.42 109.06 115.29 116.45 110.71 112.11 117.50 117.95 126.27 122.87 123.20
Days Payable Outstanding (DPO)
58.30 59.90 58.81 56.06 53.71 54.08 56.34 52.72 58.45 58.77 62.82
Cash Conversion Cycle (CCC)
118.73 117.83 126.64 128.78 127.04 130.04 135.79 138.60 139.89 137.41 133.66
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,732 6,826 7,142 7,153 6,828 6,826 6,825 6,922 6,870 7,784 7,750
Invested Capital Turnover
1.03 1.04 1.01 1.02 1.03 1.00 0.96 0.94 0.95 0.89 0.90
Increase / (Decrease) in Invested Capital
560 468 607 523 96 0.00 -317 -231 42 958 925
Enterprise Value (EV)
41,008 41,842 45,927 40,920 36,858 30,967 38,440 40,656 42,080 39,259 44,905
Market Capitalization
39,367 40,321 44,394 39,548 35,588 29,986 37,803 39,948 41,113 37,373 43,182
Book Value per Share
$17.04 $17.92 $18.94 $19.55 $18.82 $19.98 $21.12 $21.20 $20.23 $20.53 $21.10
Tangible Book Value per Share
$0.98 $1.80 $2.76 $3.39 $3.63 $4.82 $6.07 $6.26 $5.30 $3.04 $3.80
Total Capital
8,003 8,074 8,580 8,514 8,347 8,580 8,743 8,770 8,835 9,288 9,390
Total Debt
2,912 2,769 2,971 2,733 2,789 2,735 2,555 2,556 2,932 3,390 3,363
Total Long-Term Debt
2,732 2,733 2,733 2,733 2,734 2,735 2,555 2,136 2,137 3,345 3,347
Net Debt
1,641 1,521 1,533 1,372 1,270 981 637 708 967 1,886 1,723
Capital Expenditures (CapEx)
82 70 76 57 81 84 90 103 92 93 97
Debt-free, Cash-free Net Working Capital (DFCFNWC)
891 900 1,130 1,108 996 993 973 994 883 780 787
Debt-free Net Working Capital (DFNWC)
1,968 1,953 2,380 2,283 2,325 2,583 2,721 2,665 2,662 2,109 2,254
Net Working Capital (NWC)
1,788 1,917 2,142 2,283 2,270 2,583 2,721 2,245 1,867 2,064 2,238
Net Nonoperating Expense (NNE)
12 13 14 4.81 0.84 -14 -16 -9.06 -8.22 6.13 7.80
Net Nonoperating Obligations (NNO)
1,641 1,521 1,533 1,372 1,270 981 637 708 967 1,886 1,723
Total Depreciation and Amortization (D&A)
80 73 67 71 71 62 62 63 63 69 72
Debt-free, Cash-free Net Working Capital to Revenue
13.38% 13.14% 16.31% 15.74% 14.24% 14.53% 14.45% 15.08% 13.59% 11.98% 12.05%
Debt-free Net Working Capital to Revenue
29.55% 28.52% 34.34% 32.43% 33.24% 37.80% 40.40% 40.43% 40.97% 32.40% 34.50%
Net Working Capital to Revenue
26.85% 27.99% 30.91% 32.43% 32.46% 37.80% 40.40% 34.06% 28.74% 31.71% 34.26%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.10 $1.23 $1.19 $1.02 $0.38 $1.63 $1.19 $1.05 $0.97 $1.23 $1.12
Adjusted Weighted Average Basic Shares Outstanding
298M 299M 296M 296M 294M 294M 293M 293M 290M 290M 285M
Adjusted Diluted Earnings per Share
$1.10 $1.24 $1.19 $1.02 $0.38 $1.60 $1.18 $1.05 $0.97 $1.23 $1.11
Adjusted Weighted Average Diluted Shares Outstanding
299M 300M 297M 297M 295M 296M 294M 293M 291M 291M 287M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
296.04M 296.07M 295.70M 295.38M 292.59M 293.00M 293.06M 291.76M 287.33M 285.60M 285.10M
Normalized Net Operating Profit after Tax (NOPAT)
341 381 366 307 112 286 332 299 274 357 326
Normalized NOPAT Margin
19.83% 20.60% 20.83% 17.87% 6.69% 16.92% 20.00% 19.00% 17.35% 21.00% 19.38%
Pre Tax Income Margin
23.11% 24.61% 23.35% 21.96% 7.89% 24.88% 24.31% 23.78% 21.74% 23.57% 21.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
21.79 20.57 17.04 16.21 5.96 19.32 18.50 18.75 15.73 12.78 13.57
NOPAT to Interest Expense
17.93 16.56 14.63 12.78 4.66 20.97 15.07 14.95 12.44 11.16 11.64
EBIT Less CapEx to Interest Expense
17.47 17.52 14.00 13.83 2.58 15.50 14.41 13.60 11.55 9.88 10.11
NOPAT Less CapEx to Interest Expense
13.61 13.52 11.59 10.41 1.29 17.16 10.98 9.80 8.26 8.25 8.17
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
18.60% 19.94% 19.20% 19.02% 23.04% 21.37% 21.60% 21.74% 19.25% 21.26% 21.92%
Augmented Payout Ratio
104.44% 110.77% 77.17% 64.77% 78.64% 67.74% 62.06% 73.67% 82.59% 110.47% 120.41%

Frequently Asked Questions About Agilent Technologies' Financials

When does Agilent Technologies's financial year end?

According to the most recent income statement we have on file, Agilent Technologies' fiscal year ends in October. Their fiscal year 2024 ended on October 31, 2024.

How has Agilent Technologies' net income changed over the last 9 years?

Agilent Technologies' net income appears to be on an upward trend, with a most recent value of $1.29 billion in 2024, rising from $401 million in 2015. The previous period was $1.24 billion in 2023.

What is Agilent Technologies's operating income?
Agilent Technologies's total operating income in 2024 was $1.49 billion, based on the following breakdown:
  • Total Gross Profit: $3.54 billion
  • Total Operating Expenses: $2.05 billion
How has Agilent Technologies revenue changed over the last 9 years?

Over the last 9 years, Agilent Technologies' total revenue changed from $4.04 billion in 2015 to $6.51 billion in 2024, a change of 61.2%.

How much debt does Agilent Technologies have?

Agilent Technologies' total liabilities were at $5.95 billion at the end of 2024, a 20.9% increase from 2023, and a 79.8% increase since 2015.

How much cash does Agilent Technologies have?

In the past 9 years, Agilent Technologies' cash and equivalents has ranged from $1.05 billion in 2022 to $2.68 billion in 2017, and is currently $1.33 billion as of their latest financial filing in 2024.

How has Agilent Technologies' book value per share changed over the last 9 years?

Over the last 9 years, Agilent Technologies' book value per share changed from 12.57 in 2015 to 20.53 in 2024, a change of 63.3%.

Remove Ads


This page (NYSE:A) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners